Relationship of endothelial dysfunction with degree of renal function damage and lipidemic profile in patients with type 2 diabetes mellitus and hypertension.

N. O. Pertseva

doi:10.26641/2307-0404.2014.3.30342

Автор(и)

N. O. Pertseva

DOI:

https://doi.org/10.26641/2307-0404.2014.3.30342

Ключові слова:

diabetes mellitus type 2, arterial hypertension, endothelial dysfunction, renal function, lipidemic profile, relationship

Анотація

In the article defining relationship between endothelial dysfunction, the degree of renal and lipidemic profile damage in 234 patients with type 2 diabetes mellitus with hypertension was carried depending on the quality of glycemic control. It is shown that the deepening of endothelial dysfunction in patients with insufficient and poor compensation tightly correlates with the degree of renal and lipidemic disorders. In these patients there was a significant increase in the level of albuminuria, reduction in glomerular filtration rate, increase of concentrations of urea and creatinine. Against the background of poor hyperglycemia, compensation total cholesterol, low density lipoprotein content increases by 73,3% (p<0.05), hypertriglyceridemia twice exceeds the control values. In patients with type 2 diabetes mellitus with poor compensation the most significant correlation links were observed between the concentration of endothelin-1 and the level of microalbuminuria (r=+0,79), as well as the content of low density lipoprotein cholesterol (r=+0.81). Thrombomodulin concentration is in direct correlation with microalbuminuria (r=+0.76), hypercholesterolemia (r=+0.80) and hypertriglyceridemia (r=+0.83), indicating to increasing interaction between the pathogenetic mechanisms which cause depression of endothelial dysfunction, renal and dyslipidemic disorders with increasing hyperglycemia.

Біографія автора

N. O. Pertseva

SE "Dnipropetrovsk medical academy of Health Ministry of Ukraine"
Dzerzhinsky str., 9, Dnepropetrovsk, 49044, Ukraine

Посилання

Алексеев В.В. Медицинские лабораторные тех¬нологии. Руководство по клинической лабора¬торной диагностике / В.В. Алексеев, А.И. Карпи¬щен¬ко. – М. : ГЭОТАР-Медиа, 2012. – 472 с.

Аметов А.С. Сахарный диабет 2 типа. Пробле¬мы и решения / А.С. Аметов. – М. : ГЭОТАР-Медиа, 2012. – 704 с.

Зимин Ю.В. Артериальная гипертония при са¬харном диабете: особенности патогенеза и лечения (обзор) / Ю.В. Зимин // Терапевт. архив. – 1999. - № 10. – С. 15-20.

Лакин Г.Ф. Биометрия: учеб. пособие для биол. спец. вузов. / Г. Ф. Лакин. – 4-е изд., перераб. и доп. – М. : Высшая школа, 1990. – 352 с.

Сахарный диабет: острые и хронические ос¬лож¬нения / под ред. И.И. Дедова, М.В. Шестаковой. – М.: Мед. информ. агентство, 2011. – 480 с.

Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications / P. Martin-Gallan, A. Carrascosa, M. Gussinye, C. Dominguez // Free Rad. Biol. Med. – 2003. – Vol. 34, N 12. – P. 1563-1574.

Epstein M. Diabetes and hypertension: the bad companions / M. Epstein // J. Hypertension. – 1997. – Vol. 15, Suppl. 2. – P. 55-62.

Lusher T.F. Biology of the endothelium / T.F. Lu¬sher, M. Barton // Clin. Cardiol. – 1997. – Vol. 10, Suppl. 11. – P. 3-10.

Mathewkutty S. Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment / S. Mathewkutty, D.K. McGuire // Expert. Rev. Cardio¬vasc. Ther. – 2009. – Vol. 7, N 5. – P. 541-549.

Relationship between fluctuations in glucose le¬vels measured by continuous glucose monitoring and vas¬cular endothelial dysfunction in type 2 diabetes mellitus / K. Torimoto, Y. Okada, H. Mori, Y. Tanaka // Cardio¬vasc. Diabetol. – 2013. – Vol. 13. – P. 18-24.

Xu J. Molecular insights and therapeutic targets for diabetic endothelial dysfunction / J. Xu, M. N. Zou // Circulation. – 2009. – Vol. 13. – P. 1266-1286.

Alekseev VV, Karpishchenko AI. [Medical labo¬ratory technology. Manual of Clinical Laboratory Diag¬nostics]. Moscow: GEOTAR-Media, 2012;472. Russian.

Ametov AS. [Type 2 diabetes mellitus. Problems and Solutions]. Moscow: GEOTAR-Media, 2012;704. Russian.

Zimin Y. [Arterial hypertension in diabetes mel¬litus: pathogenesis and treatment characteristics (review)]. Ter. archive. 1999;10:15-20. Russian.

Lakin GF. [Biometrics: 4th ed.]. Moscow: Vys¬shaya shkola, 1990;352. Russian.

Dedov II, Shestakova MV, editors. [Diabetes: acute and chronic complications]. Moscow: "Publishing house "Medical Information Agency", 2011;480. Russian.

Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of diabetes-associated oxi¬dative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Rad. Biol. Med. 2003;34(12):1563-74.

Epstein M. Diabetes and hypertension: the bad companions. Hypertension. 1997;15(2):55-62.

Lusher TF, Barton M. Biology of the endo¬the¬lium. Clin. Cardiol. 1997;10(11):3-10.

Mathewkutty S, McGuire DK. Platelet perturba¬tions in diabetes: implications for cardiovascular disease risk and treatment. Expert. Rev. Cardiovasc. Ther. 2009;7(5):541-9.

Torimoto K, Okada Y, Mori H, Tanaka Y. Rela¬tionship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endo¬thelial dysfunction in type 2 diabetes mel¬litus. Cardio¬vasc. Diabetol. 2013;13:18-24.

Xu J, Zou MN. Molecular insights and thera¬peutic targets for diabetic endothelial dysfunction. Circu¬lation. 2009;13:1266-86.